Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy

AIMS: Previous studies have shown that baseline high viral load is closely related to treatment response in chronic hepatitis B (CHB). This study was designed to evaluate the differences of treatment responses between de novo lamivudine (LAM) plus adefovir (ADV) combination therapy compared with ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Meijin, Zhong, Jie, Lu, Chunlei, Deng, Fenglian, Li, Li, Nong, Yixi, Liang, Liudan, Qin, Houji, Deng, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814354/
https://www.ncbi.nlm.nih.gov/pubmed/31695474
http://dx.doi.org/10.2147/PGPM.S224256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814354/
https://www.ncbi.nlm.nih.gov/pubmed/31695474
http://dx.doi.org/10.2147/PGPM.S224256

Ejemplares similares